Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

313 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Retroviruses in rheumatoid arthritis.
Panayi GS, Dalgleish AG. Panayi GS, et al. Among authors: dalgleish ag. Ann Rheum Dis. 1986 May;45(5):439. doi: 10.1136/ard.45.5.439-b. Ann Rheum Dis. 1986. PMID: 3013105 Free PMC article. No abstract available.
Is Crohn's disease caused by a lymphotropic virus?
Dourmashkin RR, Sanderson I, Walker-Smith JA, Dalgleish AG. Dourmashkin RR, et al. Among authors: dalgleish ag. J Pediatr Gastroenterol Nutr. 1986 Mar-Apr;5(2):334. J Pediatr Gastroenterol Nutr. 1986. PMID: 3007719 No abstract available.
Naltrexone at low doses (LDN) and its relevance to cancer therapy.
Liu WM, Dalgleish AG. Liu WM, et al. Among authors: dalgleish ag. Expert Rev Anticancer Ther. 2022 Mar;22(3):269-274. doi: 10.1080/14737140.2022.2037426. Epub 2022 Feb 7. Expert Rev Anticancer Ther. 2022. PMID: 35107043 Free article. Review.
The immuno-oncological implications of insulin.
van Niekerk G, Dalgleish AG, Joubert F, Joubert A, Engelbrecht AM. van Niekerk G, et al. Among authors: dalgleish ag. Life Sci. 2021 Jan 1;264:118716. doi: 10.1016/j.lfs.2020.118716. Epub 2020 Nov 4. Life Sci. 2021. PMID: 33159956 Review.
Synergistic activity of agents targeting growth factor receptors, CDKs and downstream signaling molecules in a panel of pancreatic cancer cell lines and the identification of antagonistic combinations: Implications for future clinical trials in pancreatic cancer.
Khan T, Seddon AM, Dalgleish AG, Khelwatty S, Ioannou N, Mudan S, Modjtahedi H. Khan T, et al. Among authors: dalgleish ag. Oncol Rep. 2020 Dec;44(6):2581-2594. doi: 10.3892/or.2020.7822. Epub 2020 Oct 22. Oncol Rep. 2020. PMID: 33125153 Free PMC article.
313 results